{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T12:06:50Z","timestamp":1753877210602,"version":"3.41.2"},"reference-count":12,"publisher":"Oxford University Press (OUP)","issue":"12","license":[{"start":{"date-parts":[[2022,12,31]],"date-time":"2022-12-31T00:00:00Z","timestamp":1672444800000},"content-version":"vor","delay-in-days":30,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,12,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>We herein report the case of a 48-year-old man diagnosed with nodular lymphocyte-predominant Hodgkin lymphoma (NLPHL, Stage IA) and papillary thyroid carcinoma (PTC, Stage I). Total thyroidectomy, left modified neck dissection and biopsy of the right cervical lymph node were performed. Postoperatively, NLPHL treatment was prioritized, and external radiation (30.6 Gy) was applied to the right neck. PTC was considered a high-risk category for recurrence due to extranodal invasion of lymph node metastasis, and radioactive iodine therapy (ablative dose, 1110 MBq) was administered. Both PTC and NLPHL showed no recurrence 18 months after surgery.<\/jats:p>","DOI":"10.1093\/jscr\/rjac599","type":"journal-article","created":{"date-parts":[[2022,12,31]],"date-time":"2022-12-31T08:56:39Z","timestamp":1672476999000},"source":"Crossref","is-referenced-by-count":0,"title":["Simultaneous nodular lymphocyte-predominant Hodgkin lymphoma with papillary thyroid carcinoma: a case report"],"prefix":"10.1093","volume":"2022","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1148-4659","authenticated-orcid":false,"given":"Daisuke","family":"Murayama","sequence":"first","affiliation":[{"name":"Department of Breast and Thyroid Surgery, Aizawa Hospital , Matsumoto, Nagano , Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toko","family":"Hashizume","sequence":"additional","affiliation":[{"name":"Department of Breast and Thyroid Surgery, Aizawa Hospital , Matsumoto, Nagano , Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ryosuke","family":"Hirano","sequence":"additional","affiliation":[{"name":"Department of Breast and Thyroid Surgery, Aizawa Hospital , Matsumoto, Nagano , Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Koji","family":"Azuhata","sequence":"additional","affiliation":[{"name":"Department of Pathology, Aizawa Hospital , Matsumoto, Nagano , Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hisashi","family":"Shimojo","sequence":"additional","affiliation":[{"name":"Department of Pathology, Aizawa Hospital , Matsumoto, Nagano , Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nobuo","family":"Ito","sequence":"additional","affiliation":[{"name":"Department of Pathology, Aizawa Hospital , Matsumoto, Nagano , Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Osamu","family":"Mishima","sequence":"additional","affiliation":[{"name":"Department of Breast and Thyroid Surgery, Aizawa Hospital , Matsumoto, Nagano , Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2022,12,30]]},"reference":[{"key":"2022123108121188800_ref1","volume-title":"International Agency for Research on Cancer (IARC)","author":"Swerdlow","year":"2017","edition":"revised 4th"},{"key":"2022123108121188800_ref2","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1182\/blood-2005-06-2508","article-title":"Lymphoma incidence patterns by WHO subtype in the United States, 1992-2001","volume":"107","author":"Morton","year":"2006","journal-title":"Blood."},{"key":"2022123108121188800_ref3","doi-asserted-by":"crossref","first-page":"2365","DOI":"10.1182\/blood.2019003877","article-title":"Stage I-II nodular lymphocyte-predominant Hodgkin lymphoma: a multi-institutional study of adult patients by ILROG","volume":"135","author":"Binkley","year":"2020","journal-title":"Blood."},{"key":"2022123108121188800_ref4","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1200\/JCO.2009.24.9516","article-title":"Transformation to aggressive lymphoma in nodular lymphocyte-predominant Hodgkin's lymphoma","volume":"28","author":"Al-Mansour","year":"2010","journal-title":"J Clin Oncol."},{"key":"2022123108121188800_ref5","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1007\/s00268-018-4479-z","article-title":"Overall survival of papillary thyroid carcinoma patients: a single-institution long-term follow-up of 5897 patients","volume":"42","author":"Ito","year":"2018","journal-title":"World J Surg."},{"key":"2022123108121188800_ref6","first-page":"235","article-title":"Synchronous diagnosis of a Hodgkin lymphoma and a papillary carcinoma of the thyroid","volume":"1","author":"Rizkallah","year":"2014","journal-title":"Case Rep Intern Med"},{"key":"2022123108121188800_ref7","article-title":"Simultaneous Hodgkin lymphoma and BRAFV600E-positive papillary thyroid carcinoma: a case report","volume":"98","author":"Liu","year":"2019","journal-title":"Medicine (Baltimore)."},{"key":"2022123108121188800_ref8","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1182\/blood.V87.2.465.bloodjournal872465","article-title":"Distinctive expression pattern of the BCL-6 protein in nodular lymphocyte predominance Hodgkin's disease","volume":"87","author":"Falini","year":"1996","journal-title":"Blood."},{"key":"2022123108121188800_ref9","doi-asserted-by":"crossref","first-page":"S57","DOI":"10.1038\/modpathol.2012.182","article-title":"Shades of gray between large B-cell lymphomas and Hodgkin lymphomas: differential diagnosis and biological implications","volume":"26","author":"Harris","year":"2013","journal-title":"Mod Pathol."},{"key":"2022123108121188800_ref10","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.1097\/00000478-200310000-00007","article-title":"Characterization of variant patterns of nodular lymphocyte predominant hodgkin lymphoma with immunohistologic and clinical correlation","volume":"27","author":"Fan","year":"2003","journal-title":"Am J Surg Pathol."},{"key":"2022123108121188800_ref11","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1080\/10428194.2020.1852559","article-title":"Nodular lymphocyte predominant Hodgkin lymphoma: executive summary of the American radium society appropriate use criteria","volume":"62","author":"Ballas","year":"2021","journal-title":"Leuk Lymphoma."},{"key":"2022123108121188800_ref12","doi-asserted-by":"crossref","first-page":"2121","DOI":"10.1182\/blood-2018-10-877761","article-title":"Active surveillance for nodular lymphocyte-predominant Hodgkin lymphoma","volume":"133","author":"Borchmann","year":"2019","journal-title":"Blood."}],"container-title":["Journal of Surgical Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jscr\/article-pdf\/2022\/12\/rjac599\/48447982\/rjac599.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jscr\/article-pdf\/2022\/12\/rjac599\/48447982\/rjac599.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,31]],"date-time":"2022-12-31T08:56:45Z","timestamp":1672477005000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jscr\/article\/doi\/10.1093\/jscr\/rjac599\/6965554"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12,1]]},"references-count":12,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2022,12,1]]}},"URL":"https:\/\/doi.org\/10.1093\/jscr\/rjac599","relation":{},"ISSN":["2042-8812"],"issn-type":[{"type":"electronic","value":"2042-8812"}],"subject":[],"published-other":{"date-parts":[[2022,12]]},"published":{"date-parts":[[2022,12,1]]},"article-number":"rjac599"}}